Reza Ghaisvand

Reza is a postdoctoral fellow working on the project “Beta-blockers; a novel class of drug targets to block melanoma progression?”.

The project investigates associations between use beta-blockers and melanoma progression and mortality in the Norwegian population, using data from nation-wide registries.

Reza also works as a researcher at Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital.

He collaborates on several projects related to skin cancer with EpiStat research group (Epidemiological Studies of lifestyle and chronic diseases) at Department of Biostatistics, University of Oslo.

He is also collaborating with Queensland Cancer Control Analysis Team and with Population and Cancer Studies Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia on the Primary Melanoma Prevention project, a cohort study investigating melanoma recurrence after diagnosis of a localized high-risk primary tumor.

Reza has a broad interest in cancer epidemiology, in particular skin cancer and breast cancer and causal inference in cancer epidemiology.


Reza obtained his PhD from the Department of Biostatistics at University of Oslo in cancer epidemiology and biostatistics in 2016.

He worked on melanoma risk factors using data from the Norwegian Women and Cancer study (NOWAC), a large prospective cohort study including more than 170,000 participants.

During his first postdoc (2016-2019) he continued working on melanoma with more focus on heterogeneity and divergent etiological pathways of the disease.


See publications on Google Scholar